A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation

[1]  M. MacFarlane,et al.  Initiation of Apaf-1 translation by internal ribosome entry , 2000, Oncogene.

[2]  A E Willis,et al.  Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment. , 2000, Nucleic acids research.

[3]  T. Chow,et al.  A new internal-ribosome-entry-site motif potentiates XIAP- mediated cytoprotection , 1999, Nature Cell Biology.

[4]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[5]  J. Ross,et al.  Purification and Characterization of a Polysome-associated Endoribonuclease That Degrades c-myc mRNA in Vitro * , 1998, The Journal of Biological Chemistry.

[6]  G. Goodall,et al.  The vascular endothelial growth factor mRNA contains an internal ribosome entry site , 1998, FEBS letters.

[7]  Anne E. Willis,et al.  A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors , 1998, Nucleic Acids Res..

[8]  P. Einat,et al.  Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia , 1998, Molecular and Cellular Biology.

[9]  J. L. Quesne,et al.  C-Myc 5′ untranslated region contains an internal ribosome entry segment , 1998, Oncogene.

[10]  A. Prats,et al.  Alternative Translation of the Proto-oncogene c-mycby an Internal Ribosome Entry Site* , 1997, The Journal of Biological Chemistry.

[11]  S. Le,et al.  PDGF2/c-sis mRNA Leader Contains a Differentiation-linked Internal Ribosomal Entry Site (D-IRES)* , 1997, The Journal of Biological Chemistry.

[12]  V. M. Pain.  Initiation of protein synthesis in eukaryotic cells. , 1996, European journal of biochemistry.

[13]  J. Ross,et al.  mRNA stability in mammalian cells. , 1995, Microbiological reviews.

[14]  A. Prats,et al.  Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes , 1995, Molecular and Cellular Biology.

[15]  E. Domingo,et al.  Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection , 1993, Journal of virology.

[16]  D. Siegel,et al.  Biology and treatment of multiple myeloma. , 1993, Blood reviews.

[17]  G. Evan,et al.  The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.

[18]  R. Eisenman,et al.  c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock , 1988, Molecular and cellular biology.

[19]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[20]  H. Varmus,et al.  Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription , 1986, Molecular and cellular biology.

[21]  P. Pelicci,et al.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Klein,et al.  AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA , 1985, International journal of cancer.

[23]  C. Croce,et al.  The structure and nucleotide sequence of the 5' end of the human c-myc oncogene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Gray,et al.  Control of translation initiation in animals. , 1998, Annual review of cell and developmental biology.